-
Teens Turn to Substances to Relieve Stress, Putting Them at Risk in Adulthood
By Morgan Gonzales| February 21, 2024Want to read more content like this? Subscribe to Addiction Treatment Business today! Substance use during adolescence can be a crucial indicator of behavioral health issues in adulthood. Data shows more than two million adolescents aged 12 to 17 report using drugs within the last month. A new CDC study found that the most commonly reported […]
-
Want to read more content like this? Subscribe to Addiction Treatment Business today! Fee-for-service reimbursement models have contributed to a fragmented behavioral health industry. Substance use disorder (SUD) providers are set to evolve current reimbursement models to alternative payment systems in 2024. Alternative payment models, which include risk-bearing, bundled payments and shared savings, offer a brighter […]
-
SUD Providers Using Bundled-Payment Approach to Leverage Peer Support Models
By Markisan Naso| February 14, 2024Certified peer support specialists are quickly becoming an essential part of substance use disorder (SUD) treatment in the United States. Having gone through the recovery process successfully, peer support workers are driven to help others facing similar hardships in their lives. Addiction rehabilitation centers are now relying more on that connection and experience to create […]
-
Lawmakers Roll Out Bill to Bolster Addiction Treatment in State Prisons
By Chris Larson| February 12, 2024Five U.S. senators announced a bill to strengthen grant programming that supports addiction treatment in state prisons. The Supporting Treatment and Recovery Over Narcotics for Growth, Empowerment, and Rehabilitation (STRONGER) Act reauthorizes and improves the Residential Substance Abuse Treatment for State Prisoners (RSAT) program. It adds more funding for training the state officials who oversee […]
-
A slew of states are pursuing Medicaid coverage for incarcerated populations ahead of their release from prison as a means to address substance use disorders. In Jan. of 2023, California received federal approval to provide people in correctional facilities with Medicaid services before their release. One year later, a “groundswell” of other states seek to […]
-
Cannabis-Related Emergency Department Visits Increased Nearly 50%
By Morgan Gonzales| February 7, 2024The rate of cannabis-induced and cannabis-involved disorder emergency department (ED) visits rose nearly 50% between 2019 and 2020, according to a new study by Truveta Research. Despite this trend, clinicians may not feel empowered to treat cannabis-related conditions. The medical community uses the term cannabis-induced ED to describe what is known as cannabis-induced psychosis. Cannabis-involved […]
-
The substance use disorder (SUD) industry has dramatically changed in recent years, adjusting to new technology, regulations and medications. The SUD platform of the future will take into account trends with payers and technology, industry insiders told Addiction Treatment Business, and continually re-educate itself on the best treatment modalities. Still, future-proofing SUD providers must keep […]
-
Virtual mental health provider Talkspace (Nasdaq: TALK) has inked a deal with digital addiction operator Bicycle Health to provide both companies’ patients with access to both therapy and opioid use disorder (OUD) treatment. More than 21 million adults have both a mental illness and substance use disorder (SUD), according to the 2022 National Survey on […]
-
In recent years, substance use disorder (SUD) treatment programs have become shorter and outpatient treatment program options have become more popular. Residential inpatient treatment programs, often more expensive than outpatient options, may be going out of vogue among payers and investors. Still, patients will always need an option for residential care, industry insiders told Addiction […]
-
A class of synthetic opioids that are 10 times as potent as fentanyl is becoming increasingly prevalent in the United States. The substance use disorder (SUD) industry may not be sufficiently prepared for its impacts. Nitazenes, a class of synthetic opioids first developed in the 1950s as opioid analgesics and never approved to market, are […]